BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 15200441)

  • 1. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival.
    Sagedal S; Hartmann A; Nordal KP; Osnes K; Leivestad T; Foss A; Degré M; Fauchald P; Rollag H
    Kidney Int; 2004 Jul; 66(1):329-37. PubMed ID: 15200441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival.
    Smedbråten YV; Sagedal S; Leivestad T; Mjøen G; Osnes K; Rollag H; Reisaeter AV; Foss A; Os I; Hartmann A
    Clin Transplant; 2014 Jan; 28(1):120-6. PubMed ID: 24351078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality risk.
    Sagedal S; Rollag H; Hartmann A
    Clin Transplant; 2007; 21(3):309-13. PubMed ID: 17488378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
    Reischig T; Jindra P; Svecová M; Kormunda S; Opatrný K; Treska V
    J Clin Virol; 2006 Jun; 36(2):146-51. PubMed ID: 16531113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients.
    Hasegawa J; Hatakeyama S; Wakai S; Omoto K; Okumi M; Tanabe K; Mieno M; Shirakawa H
    Int J Infect Dis; 2017 Dec; 65():50-56. PubMed ID: 28986314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection in renal transplant recipients: one center's experience.
    Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
    Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
    Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
    Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
    Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The significance of risk-adapted antiviral prophylaxis and modern virus diagnosis for organ survival after kidney transplantation].
    Fricke L; Steinhoff J; Hartwig-Weber I; Bein G
    Dtsch Med Wochenschr; 1997 May; 122(18):565-71. PubMed ID: 9190308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation.
    Arthurs SK; Eid AJ; Pedersen RA; Kremers WK; Cosio FG; Patel R; Razonable RR
    Clin Infect Dis; 2008 Mar; 46(6):840-6. PubMed ID: 18260785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural course of cytomegalovirus infection and disease in renal transplant recipients.
    Hartmann A; Sagedal S; Hjelmesaeth J
    Transplantation; 2006 Jul; 82(2 Suppl):S15-7. PubMed ID: 16858268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
    Fallatah SM; Marquez MA; Bazerbachi F; Schiff JR; Cattral MS; McGilvray ID; Norgate A; Selzner M; Rotstein C; Husain S
    Clin Transplant; 2013; 27(4):503-9. PubMed ID: 23731387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis.
    Rayes N; Seehofer D; Kahl A; Kokott S; Pratschke J; Frei U; Neuhaus P
    Transpl Int; 2007 Nov; 20(11):974-81. PubMed ID: 17680782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic CMV therapy does not improve three-yr patient and graft survival compared to preemptive therapy.
    Werzowa J; Schwaiger B; Hecking M; Strassl R; Schmaldienst S; Böhmig GA; Genser B; Säemann MD
    Clin Transplant; 2015 Dec; 29(12):1230-8. PubMed ID: 26458731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus infection and graft rejection in renal transplantation.
    Dickenmann MJ; Cathomas G; Steiger J; Mihatsch MJ; Thiel G; Tamm M
    Transplantation; 2001 Mar; 71(6):764-7. PubMed ID: 11330539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival.
    Helanterä I; Koskinen P; Finne P; Loginov R; Kyllönen L; Salmela K; Grönhagen-Riska C; Lautenschlager I
    Transpl Int; 2006 Nov; 19(11):893-900. PubMed ID: 17018124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.
    Kranz B; Vester U; Wingen AM; Nadalin S; Paul A; Broelsch CE; Hoyer PF
    Pediatr Transplant; 2008 Jun; 12(4):474-8. PubMed ID: 18466436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of viral load and time to onset of cytomegalovirus replication on long-term graft survival after kidney transplantation.
    Reischig T; Kacer M; Hruba P; Jindra P; Hes O; Lysak D; Bouda M; Viklicky O
    Antivir Ther; 2017; 22(6):503-513. PubMed ID: 28091392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
    Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E;
    Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.